Business
Willow Biosciences to Commence Trading on The OTCQX® Best Market
Willow Biosciences to Commence Trading on The OTCQX® Best Market Canada NewsW...
About this update from Atlas Energy Corp.
[{"type":"text","content":"\n\n\n\nWillow Biosciences to Commence Trading on The OTCQX® Best Market\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, BC, July 22, 2020\n\n\n\nVANCOUVER, BC, July 22, 2020 /CNW/ - Willow Biosciences Inc. (\"Willow\" or the \"Company\") (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has been approved to commence trading on the OTCQX® Best Market (the \"OTCQX\"), beginning today, July 22, 2020, under the symbol \"CANSF\". Willow has upgraded to the OTCQX from the OTCQB® Venture Market (the \"OTCQB\"). U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.\n\n \n \n \n \n \n \n\n \n\"We are very excited to migrate to the top of the OTC market, the OTCQX® Best Market,\" said Trevor Peters, President and Chief Executive Officer of Willow. \"This is a key milestone for us and allows for prospective U.S. investors to more easily invest in the Company. It is also a testament to our mandate to have the utmost regard for transparency and corporate governance. We are excited to continue to deliver on our milestones and expand our U.S. retail and institutional investor base.\"\nThe OTCQX is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX from the OTCQB marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.\nAbout Willow Biosciences Inc.\nWillow is a Canadian biotechnology company based in Vancouver, British Columbia, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow's current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indication...